Get the Stockscreener App
0.00
100.00%
-17.16
After Hours:
1.46
1.46
+
Ikena Oncology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
See More
Previous Close:
$17.16
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$59.90M
Revenue:
$9.16M
Net Income/Loss:
$-68.17M
P/E Ratio:
0.00
EPS:
-1.63
Net Cash Flow:
$-80.16M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.28
Ikena Oncology Inc Stock (IKNA) Company Profile
Name
Ikena Oncology Inc
Sector
Industry
Phone
857-343-8292
Address
50 NORTHERN AVE., BOSTON
Compare IKNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
0.00 | 59.90M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-24 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-22-23 | Initiated | Wedbush | Outperform |
| May-04-23 | Resumed | H.C. Wainwright | Buy |
| Dec-23-21 | Initiated | H.C. Wainwright | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Jefferies | Buy |
| Apr-20-21 | Initiated | William Blair | Outperform |
View All
Ikena Oncology Inc Stock (IKNA) Latest News
Why Ikena Oncology Inc. stock could outperform in 2025Weekly Investment Summary & Fast Entry High Yield Stock Tips - newser.com
Applying big data sentiment scoring on Ikena Oncology Inc.July 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Using AI based signals to follow Ikena Oncology Inc.July 2025 Selloffs & Risk Managed Investment Strategies - newser.com
Why Ikena Oncology Inc. stock is favored by top institutions2025 Analyst Calls & Entry Point Strategy Guides - newser.com
What catalysts could drive Ikena Oncology Inc. stock higherMarket Performance Report & Verified Short-Term Trading Plans - newser.com
How Ikena Oncology Inc. stock trades during market volatilityJuly 2025 Reactions & Community Supported Trade Ideas - newser.com
Is Ikena Oncology Inc. stock attractive for growth ETFsQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Ikena Oncology Inc. stock momentum explainedMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
What technical models suggest about Ikena Oncology Inc.’s comebackWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Ikena Oncology Inc. stock go up soon2025 Analyst Calls & Verified Entry Point Detection - newser.com
Can momentum traders help lift Ikena Oncology Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
What analysts say about Ikena Oncology Inc stockFibonacci Retracement Levels & Small Entry Portfolio - earlytimes.in
Will Ikena Oncology Inc. stock recover after recent dropGap Down & Long-Term Investment Growth Plans - newser.com
What machine learning models say about Ikena Oncology Inc.Entry Point & Verified Short-Term Plans - newser.com
Is Ikena Oncology Inc. stock trading at a premium valuation2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Does Ikena Oncology Inc. qualify in momentum factor screeningEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Using Bollinger Bands to evaluate Ikena Oncology Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Will Ikena Oncology Inc. continue its uptrendJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Ikena Oncology Inc. stock outlook for YEAR2025 Volatility Report & Stock Portfolio Risk Control - newser.com
United States Neurofibromatosis Type 2 Market Set to Surge with - openPR.com
Ikena Oncology Inc Stock (IKNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.09%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):